What is NDC 0143-9241?

0143-9241 is the product NDC for Bleomycin, Bleomycin sulfate 30 [USP'U]/1 injection, powder, lyophilized, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bleomycin?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bleomycin NDC 0143-9241 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9241Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9241Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9241-01	0014392410100143924101	1 VIAL in 1 BOX, UNIT-DOSE (0143-9241-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIALMarketed from Jan 9, 2018

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bleomycin
Generic name (nonproprietary): bleomycin
Active ingredients: Bleomycin sulfate — 30 [USP'U]/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular, Intrapleural, Intravenous, Subcutaneous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065042
Marketing start: Jan 9, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 0143-9241_c8047994-3b3a-4e16-809b-786e47014fe9SPL ID c8047994-3b3a-4e16-809b-786e47014fe9SPL set ID cccfb763-79fa-4186-89fb-d8d061d3c161RxCUI 1726673, 1726676UNII 7DP3NTV15T
Pharmacologic class: Cytoprotective Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143924101 followed by a unit qualifier and the quantity

Package 00143-9241-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 11, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bleomycin for Injection, USP should be considered a palliative treatment. It has been shown to be useful in the management of the Squamous Cell Carcinoma Head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to bleomycin is poorer in patients with previously irradiated head and neck cancer. Lymphomas Hodgkin's disease, non-Hodgkin's lymphoma. Testicular Carcinoma Embryonal cell, choriocarcinoma, and teratocarcinoma. Bleomycin for Injection, USP has also been shown to be useful in the management of: Malignant Pleural Effusion Bleomycin is effe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9241

What is NDC 0143-9241?: 0143-9241 is the product NDC for Bleomycin, Bleomycin sulfate 30 [USP'U]/1 injection, powder, lyophilized, for solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bleomycin.
What is the active ingredient?: Bleomycin sulfate.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bleomycin?: 11 other product NDCs are listed under this name. See all Bleomycin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bleomycin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bleomycin	Bleomycin sulfate 15 [USP'U]/1	Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	NorthStar Rx LLC	16714-886	16714-0886-01
Bleomycin	Bleomycin sulfate 30 [USP'U]/1	Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	NorthStar Rx LLC	16714-908	16714-0908-01
Bleomycinbleomycin sulfate	Bleomycin sulfate 15 [USP'U]/1	Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Meitheal Pharmaceuticals Inc.	71288-106	71288-0106-10
Bleomycinbleomycin sulfate	Bleomycin sulfate 30 [USP'U]/1	Powder, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Meitheal Pharmaceuticals Inc.	71288-107	71288-0107-20
Bleomycin	Bleomycin sulfate 30 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hospira, Inc.	0409-0323	00409-0323-20
Bleomycin	Bleomycin sulfate 15 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9240	00143-9240-01
Bleomycin	Bleomycin sulfate 15 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hospira, Inc.	0409-0332	00409-0332-20
Bleomycinbleomycin sulfate	Bleomycin sulfate 15 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Fresenius Kabi USA, LLC	63323-136	63323-0136-10
Bleomycinbleomycin sulfate	Bleomycin sulfate 30 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Fresenius Kabi USA, LLC	63323-137	63323-0137-20
Bleomycin	Bleomycin sulfate 15 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hospira, Inc.	61703-332	61703-0332-18

All 12 Bleomycin NDCs

Other NDCs under ANDA 065042

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065042
Product	Strength	Form · route	Labeler	Product NDC
Bleomycin	Bleomycin sulfate 15 [USP'U]/1	Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9240